TGF-β Specifies T Versus T17 Cell Fates in Murine CD4 T Cells Through C-Maf
Overview
Authors
Affiliations
T follicular helper (T) cells are essential for effective antibody responses, but deciphering the intrinsic wiring of mouse T cells has long been hampered by the lack of a reliable protocol for their generation in vitro. We report that transforming growth factor-β (TGF-β) induces robust expression of T hallmark molecules CXCR5 and Bcl6 in activated mouse CD4 T cells in vitro. TGF-β-induced mouse CXCR5 T cells are phenotypically, transcriptionally, and functionally similar to in vivo-generated T cells and provide critical help to B cells. The study further reveals that TGF-β-induced CXCR5 expression is independent of Bcl6 but requires the transcription factor c-Maf. Classical TGF-β-containing T helper 17 (T17)-inducing conditions also yield separate CXCR5 and IL-17A-producing cells, highlighting shared and distinct cell fate trajectories of T and T17 cells. We demonstrate that excess IL-2 in high-density T cell cultures interferes with the TGF-β-induced T cell program, that T and T17 cells share a common developmental stage, and that c-Maf acts as a switch factor for T versus T17 cell fates in TGF-β-rich environments in vitro and in vivo.
STING Deficiency Promotes Th17-Like Tfh to Aggravate the Experimental Autoimmune Uveitis.
Li Z, Liu X, Li Z, Xiao Z, Chen G, Li Y Invest Ophthalmol Vis Sci. 2025; 66(3):8.
PMID: 40042874 PMC: 11892529. DOI: 10.1167/iovs.66.3.8.
Wurnig S, Huber M, Weiler C, Baltrukevich H, Merten N, Stotzel I J Med Chem. 2025; 68(4):4308-4333.
PMID: 39937529 PMC: 11873976. DOI: 10.1021/acs.jmedchem.4c02102.
Systemic inflammation and lymphocyte activation precede rheumatoid arthritis.
He Z, Glass M, Venkatesan P, Feser M, Lazaro L, Okada L bioRxiv. 2024; .
PMID: 39554042 PMC: 11565773. DOI: 10.1101/2024.10.25.620344.
Fahlberg M, Forward S, Assita E, Mazzola M, Kiem A, Handley M bioRxiv. 2024; .
PMID: 39185194 PMC: 11343140. DOI: 10.1101/2024.08.13.607771.
An intestinal T17 cell-derived subset can initiate cancer.
Fesneau O, Thevin V, Pinet V, Goldsmith C, Vieille B, MHoma Soudja S Nat Immunol. 2024; 25(9):1637-1649.
PMID: 39060651 PMC: 11362008. DOI: 10.1038/s41590-024-01909-7.